Ken Frazier, CEO of Merck, tells CNBC about the challenges of finding new blockbuster drugs and how any change to Medicare funding must have a sustainable benefit.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT